Related Experiment Video
Updated: Jun 7, 2026
07:39
Mouse In Vivo Placental Targeted CRISPR Manipulation
Published on: April 14, 2023
Combination of promoter hypomethylation and PDX1 overexpression leads to TBX15 decrease in vascular IUGR placentas
Sonia T Chelbi1, Ludivine Doridot, Françoise Mondon
1Institut Cochin, Université Paris Descartes, CNRS (UMR 8104), Paris, France.
Epigenetics
|October 22, 2010
Summary
Epigenetic changes in placental DNA, specifically in the TBX15 gene promoter, are linked to pregnancy complications like preeclampsia and fetal growth restriction. Hypomethylation of TBX15 correlates with reduced expression and newborn size.
Area of Science:
- Obstetrics and Gynecology
- Epigenetics
- Developmental Biology
Background:
- Preeclampsia (PE) and vascular intra-uterine growth restriction (vIUGR) are significant pregnancy complications stemming from placental dysfunction.
- Epigenetic modifications, particularly DNA methylation, are increasingly recognized as crucial in the pathophysiology of these conditions.
Purpose of the Study:
- To investigate the role of epigenetic alterations in the TBX15 gene promoter in pathological placental conditions.
- To explore the relationship between placental methylation patterns, TBX15 expression, and newborn anthropometrics.
Main Methods:
- Analysis of DNA methylation patterns in the distal promoter region of the TBX15 gene in pathological placentas.
- Correlation of methylation levels with newborn weight and stature.
- Assessment of TBX15 mRNA expression and its regulation by transcription factors like PDX1.
Main Results:
- A specific region in the TBX15 promoter showed differential methylation in pathological placentas.
- Hypomethylation of the TBX15 promoter was observed in vIUGR, associated with decreased TBX15 expression.
- Methylation levels significantly correlated with newborn weight and stature.
- PDX1 demonstrated methylation-dependent repression of the TBX15 promoter.
Conclusions:
- TBX15 gene promoter methylation is altered in placental pathologies.
- TBX15 may play a role in the pathophysiology of preeclampsia and vIUGR.
- Epigenetic regulation of TBX15 by factors like PDX1 could contribute to impaired fetal development.
Related Concept Videos
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
02:30Genomic Imprinting and Inheritance
Diploid organisms inherit genetic material through chromosomes from both parents. Copies of the same gene are known as alleles. In most cases, both alleles are simultaneously expressed and allow various cellular processes to function optimally. If one of the alleles is missing or mutated, the expression of the other allele can compensate; however, this is not true for all genes.
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
01:24Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
01:07Teratogenicity
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...